Recent studies have demonstrated the link between increased expression of inflammatory markers, including MMP-2 and MMP-9, in amniotic fluid during pregnancy or in tears of premature neonates and ROP development and progression [17,18,19]. This evidence concerns the gene MMP9 and retinopathy of prematurity.